Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Regulatory Filings 2021

Aug 25, 2021

33003_rns_2021-08-25_9de24b20-6a51-476b-8546-3c0456a94255.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm CORRESP

August 25, 2021

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Re: Solid Biosciences Inc.

Registration Statement on Form S-3

File No. 333-258859

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-258859), so that it may become effective at 4:30 p.m., Eastern time, on August 27, 2021, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

Very truly yours,
By: /s/ Ilan Ganot
Ilan Ganot
Chief Executive Officer